secwatch / observer

8-K filed October 16, 2024, 7:59 PM ET ticker LCID CIK 0001811210

other material confidence high sentiment neutral materiality 0.90

Lucid Group announces preliminary Q3 results and public offering of common stock, with PIF affiliate investment

Lucid Group, Inc.

Preliminary Q3 2024 revenue estimated between $199M and $200M, and loss from operations between $765M and $790M.
Vehicle production of 1,805 units and deliveries of 2,781 units in Q3 2024.
Public offering of 262,446,931 shares commenced; underwriter option for additional 39,367,040 shares.
Majority stockholder Ayar to purchase 374,717,927 shares in concurrent private placement, maintaining ~58.8% ownership.

item 2.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-24-109242
form_type: 8-K
ticker: LCID
cik: 0001811210
company_name: Lucid Group, Inc.
filed_at: 2024-10-16T23:59:59+00:00
discovered_at: 2026-05-14T18:03:09.744206+00:00
generated_at: 2026-05-30T14:06:28.391924+00:00
sec_items: ["2.02", "7.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-24-109242
json_url: https://secwatch.observer/filing/0001104659-24-109242.json
markdown_url: https://secwatch.observer/filing/0001104659-24-109242.md
text_url: https://secwatch.observer/filing/0001104659-24-109242.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1811210/000110465924109242/0001104659-24-109242-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1811210/000110465924109242/tm2426052d7_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

IDYA

IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma

IDEAYA Biosciences, Inc. June 1, 2026, 4:05 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

MDAI

Spectral AI gets FDA clearance for DeepView burn indication; targets first commercial sales by year-end 2026

Spectral AI, Inc. June 1, 2026, 4:01 PM ET other_material Items 5.07, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

LIXT

Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

LIXTE BIOTECHNOLOGY HOLDINGS, INC. June 1, 2026, 8:55 AM ET other_material Items 5.02, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

OPTU

Optimum raises $500M via preferred units, starts $300M tender at $2.50 to shield assets from CSC debt

Optimum Communications, Inc. June 1, 2026, 8:16 AM ET other_material Items 1.01, 3.02, 7.01, 8.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

JSPR

Jasper Therapeutics initiates strategic review including potential sale or wind-down

Jasper Therapeutics, Inc. June 1, 2026, 8:01 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

EIKN

Eikon reports 63.1% ORR in Phase 2 NSCLC trial of EIK1001; PARP1 inhibitor EIK1003 shows 24.5% ORR with paclitaxel

Eikon Therapeutics, Inc. June 1, 2026, 7:30 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

FULC

Fulcrum Therapeutics discontinues pociredir program in SCD; initiates strategic review

Fulcrum Therapeutics, Inc. June 1, 2026, 4:05 PM ET other_material Items 8.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

GPRO

GoPro refiles financials with going-concern warning; potential defaults on debt

GoPro, Inc. June 1, 2026, 9:12 AM ET other_material Items 8.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001104659-24-109242

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.